Rhythm Pharmaceuticals, Inc. RYTM Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s free cash flow yield?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported free cash flow yield of -1.6% in Q4 2025.
- How has Rhythm Pharmaceuticals, Inc.'s free cash flow yield changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s free cash flow yield increased by 50.7% year-over-year, from -3.3% to -1.6%.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s free cash flow yield?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s free cash flow yield has grown at a -51.4% compound annual growth rate (CAGR), from -29.2% to -1.6%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.